HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effects of inhaled nitric oxide on primary graft dysfunction in lung transplantation.

AbstractINTRODUCTION AND OBJECTIVES:
Inhaled nitric oxide (iNO) is a gaseous drug with known properties of specific pulmonary vasodilation and improved oxygenation. In some clinical trials on lung transplantation (LT) in animals, it has been demonstrated to reduce primary graft dysfunction (PGD) by limiting neutrophil adhesion and the inflammatory cascade. Our objective was to assess whether iNO showed this immunomodulatory effect by determining interleukin (IL)-6, -8, and -10 levels in blood and bronchoalveolar lavage (BAL) in LT patients, and its relationship with PGD incidence.
MATERIALS AND METHODS:
Forty-nine LT patients were recruited and included in the iNO or in the control group. Patients in the first group were given iNO (10 ppm) from the start of LT to 48 hours afterward. BAL and blood samples were taken preimplantation and at 12, 24, and 48 hours after graft reperfusion.
RESULTS:
The iNO group displayed a significantly lower incidence (P < .035) of PGD (17.2%) than the control group (45%). Significant differences (P < .05) were also observed in the iNO group with lower levels of IL-6 (in blood at 12 hours), IL-8 (in blood and BAL at 12 and 24 hours), and IL-10 (in blood at 12 and 24 hours and BAL at 24 hours).
CONCLUSIONS:
PGD is associated with the development of an inflammatory process that is reduced by giving iNO to lung recipients. In our series, the iNO group displayed significantly lower content of IL-6, IL-8, and IL-10 in the majority of samples at 12 and 24 hours compared with the control group.
AuthorsI Moreno, R Vicente, A Mir, I León, F Ramos, J L Vicente, M Barbera
JournalTransplantation proceedings (Transplant Proc) 2009 Jul-Aug Vol. 41 Issue 6 Pg. 2210-2 ISSN: 1873-2623 [Electronic] United States
PMID19715875 (Publication Type: Journal Article)
Chemical References
  • Interleukin-6
  • Interleukin-8
  • Interleukin-10
  • Nitric Oxide
Topics
  • Administration, Inhalation
  • Adolescent
  • Adult
  • Aged
  • Female
  • Humans
  • Interleukin-10 (blood)
  • Interleukin-6 (blood)
  • Interleukin-8 (blood)
  • Lung Transplantation (physiology)
  • Male
  • Middle Aged
  • Nitric Oxide (administration & dosage, therapeutic use)
  • Postoperative Complications (prevention & control)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: